September 16 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said that local Donev Investments Holding has acquired 700 shares in the company at a weighed average price per share of 6.45 levs ($3.66/3.30 euro).
Donev Investments Holding acquired the shares on the floor of the Bulgarian Stock Exchange on September 11, Sopharma Trading said in a bourse filing on Friday.
Donev Investments Holding is controlled by the chairman of Sopharma Trading's board of directors - Ognyan Donev. Donev is also the CEO of Sopharma Trading's majority owner - drug maker Sopharma [BUL:3JR].
At the end of June, Sopharma held a 72.97% stake in Sopharma Trading, while Donev Investments Holding held directly a stake of under 5%.
Sopharma Trading shares closed 0.78% lower at 6.40 levs on the Bulgarian Stock Exchange on Friday.
(1 euro = 1.95583 levs)